Literature DB >> 26297922

Crispld2 is required for neural crest cell migration and cell viability during zebrafish craniofacial development.

Eric C Swindell1,2, Qiuping Yuan1, Lorena E Maili1,2, Bhavna Tandon3, Daniel S Wagner3, Jacqueline T Hecht1,2,4.   

Abstract

The CAP superfamily member, CRISPLD2, has previously been shown to be associated with nonsyndromic cleft lip and palate (NSCLP) in human populations and to be essential for normal craniofacial development in the zebrafish. Additionally, in rodent models, CRISPLD2 has been shown to play a role in normal lung and kidney development. However, the specific role of CRISPLD2 during these developmental processes has yet to be determined. In this study, it was demonstrated that Crispld2 protein localizes to the orofacial region of the zebrafish embryo and knockdown of crispld2 resulted in abnormal migration of neural crest cells (NCCs) during both early and late time points. An increase in cell death after crispld2 knockdown as well as an increase in apoptotic marker genes was also shown. This data suggests that Crispld2 modulates the migration, differentiation, and/or survival of NCCs during early craniofacial development. These results indicate an important role for Crispld2 in NCC migration during craniofacial development and suggests involvement of Crispld2 in cell viability during formation of the orofacies.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  birth defects; early development; migration; neural crest

Mesh:

Substances:

Year:  2015        PMID: 26297922      PMCID: PMC6258193          DOI: 10.1002/dvg.22897

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  36 in total

Review 1.  Crosstalk between apoptosis, necrosis and autophagy.

Authors:  Vassiliki Nikoletopoulou; Maria Markaki; Konstantinos Palikaras; Nektarios Tavernarakis
Journal:  Biochim Biophys Acta       Date:  2013-06-13

2.  Association of MMP3 and TIMP2 promoter polymorphisms with nonsyndromic oral clefts.

Authors:  Ariadne Letra; Renato M Silva; Luise G Motta; Susan H Blanton; Jacqueline T Hecht; Jose M Granjeirol; Alexandre R Vieira
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-06-22

Review 3.  A long-awaited merger of the pathways mediating host defence and programmed cell death.

Authors:  J Magarian Blander
Journal:  Nat Rev Immunol       Date:  2014-09       Impact factor: 53.106

4.  The CRISPLD2 gene is involved in cleft lip and/or cleft palate in a Chinese population.

Authors:  Xi Shen; Rui-Min Liu; Lan Yang; Hua Wu; Pei-Qiang Li; Ya-Ling Liang; Xiao-Dong Xie; Ting Yao; Ting-Ting Zhang; Min Yu
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-07-28

5.  Both LCCL-domains of human CRISPLD2 have high affinity for lipid A.

Authors:  Viktor Vásárhelyi; Mária Trexler; László Patthy
Journal:  Biochimie       Date:  2013-10-01       Impact factor: 4.079

6.  Retinoids and TIMP1 prevent radiation-induced apoptosis of capillary endothelial cells.

Authors:  Ekaterina Vorotnikova; Mark Tries; Susan Braunhut
Journal:  Radiat Res       Date:  2004-02       Impact factor: 2.841

7.  The novel lipopolysaccharide-binding protein CRISPLD2 is a critical serum protein to regulate endotoxin function.

Authors:  Zhi-Qin Wang; Wen-Ming Xing; Hua-Hua Fan; Ke-Sheng Wang; Hai-Kuo Zhang; Qin-Wan Wang; Jia Qi; Hong-Meng Yang; Jie Yang; Ya-Na Ren; Shu-Jian Cui; Xin Zhang; Feng Liu; Dao-Hong Lin; Wen-Hui Wang; Michael K Hoffmann; Ze-Guang Han
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

8.  Invasion of a basement membrane matrix by chick embryo primitive streak cells in vitro.

Authors:  E J Sanders; S Prasad
Journal:  J Cell Sci       Date:  1989-03       Impact factor: 5.285

9.  CRISPLD2 is a target of progesterone receptor and its expression is decreased in women with endometriosis.

Authors:  Jung-Yoon Yoo; Heesung Shin; Tae Hoon Kim; Won-Seok Choi; Susan D Ferguson; Asgerally T Fazleabas; Steven L Young; Bruce A Lessey; Un-Hwan Ha; Jae-Wook Jeong
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

10.  Inflammatory cytokines, goblet cell hyperplasia and altered lung mechanics in Lgl1+/- mice.

Authors:  Jie Lan; Leslie Ribeiro; Isabel Mandeville; Katia Nadeau; Tim Bao; Salomon Cornejo; Neil B Sweezey; Feige Kaplan
Journal:  Respir Res       Date:  2009-09-21
View more
  6 in total

Review 1.  Zebrafish models of orofacial clefts.

Authors:  Kaylia M Duncan; Kusumika Mukherjee; Robert A Cornell; Eric C Liao
Journal:  Dev Dyn       Date:  2017-09-25       Impact factor: 3.780

2.  Knockdown of Crispld2 in zebrafish identifies a novel network for nonsyndromic cleft lip with or without cleft palate candidate genes.

Authors:  Brett T Chiquet; Qiuping Yuan; Eric C Swindell; Lorena Maili; Robert Plant; Jeffrey Dyke; Ryan Boyer; John F Teichgraeber; Matthew R Greives; John B Mulliken; Ariadne Letra; Susan H Blanton; Jacqueline T Hecht
Journal:  Eur J Hum Genet       Date:  2018-06-13       Impact factor: 4.246

3.  Investigation of candidate genes of non-syndromic cleft lip with or without cleft palate, using both case-control and family-based association studies.

Authors:  Xing Ge; Jia-Wei Hong; Jun-Yu Shen; Zheng Li; Rui Zhang; Qi Wang; Zhen Ding; Gang Chen; Li-Chun Xu
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

4.  Gene expression profiling of upregulated mRNAs in granulosa cells of bovine ovulatory follicles following stimulation with hCG.

Authors:  Jacques G Lussier; Mame N Diouf; Valérie Lévesque; Jean Sirois; Kalidou Ndiaye
Journal:  Reprod Biol Endocrinol       Date:  2017-11-03       Impact factor: 5.211

Review 5.  Non-syndromic Cleft Palate: An Overview on Human Genetic and Environmental Risk Factors.

Authors:  Marcella Martinelli; Annalisa Palmieri; Francesco Carinci; Luca Scapoli
Journal:  Front Cell Dev Biol       Date:  2020-10-20

Review 6.  Orofacial Cleft and Mandibular Prognathism-Human Genetics and Animal Models.

Authors:  Anna Jaruga; Jakub Ksiazkiewicz; Krystian Kuzniarz; Przemko Tylzanowski
Journal:  Int J Mol Sci       Date:  2022-01-16       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.